October 3, 2022

OncoHost: Chris Dingman, James Whelan

Original source here.

OncoHost announced that it has named Chris Dingman chief commercial officer.

Dingman was previously area director of the Western United States and CancerType ID commercial lead at Biotheranostics, a Hologic company. He previously held positions at Life Technologies, Caris, Merck Pharmaceuticals and Sanofi.

Additionally, James Whelan has joined the company's board of directors. Whelan was previously senior vice president of managed care for Laboratory Corporation of America. He has also held leadership roles at BioMérieux, Magellan Biosciences, and Fisher Scientific.